The O2matic Story
First prototype was developed, and through a PC it actually was able to regulate Oxygen due to a measured Saturation. But still far away from an approved medical device.
The development continued, but due to it was a project that took place in “spare time”, it took quite a bit longer than expected as regulatory requirements got known. Several times it was considered to stop the project due to costs and lack of time.
Prototype 3 was developed, and as shown still not tried on a real patient. In 2016 the project was supported with a Grand Solution grant from the Innovationsfund, Denmark. The support from the Innovationfund was a turning point – Thank you, Innovationfund, Denmark.
In 2018, O2matic was certified as an ISO 13485:2016 company. Finally February 2019 our product O2matic Pro has reached its goal, a CE-mark, that allows us to enter market in all of EU. In the same time we have entered a collaboration with Linde AG, the world largest gas supplier, to distribute in seven European Countries.
The team behind the O2matic Pro idea.
From the left:
Lars Seier-Petersen – Greendale Medical Engineering and member of the board O2matic ApS, Søren Hansen – Associate Professor DTU Electro, Okan Ilker Görgen – CEO O2matic ApS, Ejvind Frausing – Chief physician Hvidovre Hospital and chairman of the board O2matic ApS, Farzad Saber – CPO and vice chairman of the board Ommatic ApS, Nils Axel Andersen – Associate Professor DTU Elektro, Jens Hove – MD Hvidovre Hospital and member of the board O2matic ApS.